{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Amrinone  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Amrinone. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Amrinone  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "amrinone",
    "trial_2_text": "Amrinone  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Amrinone Supplement: 60 participants will take Amrinone 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Amrinone. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Amrinone  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.23993591964244843,
      "78": 0.20152512192726135,
      "123": 0.13885661959648132,
      "67": 0.13581694662570953,
      "177": 0.13236932456493378,
      "17": 0.12745115160942078,
      "68": 0.12173867970705032,
      "46": 0.11405551433563232,
      "173": 0.11131873726844788,
      "20": 0.1104792132973671,
      "189": 0.11033033579587936,
      "228": 0.10984420031309128,
      "37": 0.10765088349580765,
      "2": 0.1029532253742218,
      "21": 0.10205212235450745,
      "9": 0.09782152622938156,
      "49": 0.09700308740139008,
      "200": 0.09565167129039764,
      "350": 0.09549448639154434,
      "188": 0.09134011715650558,
      "193": 0.08884920179843903,
      "79": 0.08756580203771591,
      "14": 0.08729802072048187,
      "101": 0.08663219213485718,
      "64": 0.07944473624229431,
      "5": 0.07335859537124634,
      "77": 0.06969572603702545,
      "243": 0.06574966013431549,
      "72": 0.06419502943754196,
      "86": 0.0637313649058342,
      "29": 0.06246049329638481,
      "194": 0.0619344562292099,
      "126": 0.061396997421979904,
      "239": 0.06135895848274231,
      "114": 0.061240170150995255,
      "179": 0.05676978826522827,
      "28": 0.05492749065160751,
      "122": 0.05445447191596031,
      "27": 0.05430428683757782,
      "151": 0.05206902325153351,
      "85": 0.05054498463869095,
      "191": 0.04993969574570656,
      "61": 0.04976709932088852,
      "144": 0.049058329313993454,
      "139": 0.04904966428875923,
      "355": 0.048611629754304886,
      "38": 0.04857323691248894,
      "76": 0.04840061068534851,
      "276": 0.04834449291229248,
      "104": 0.04825393855571747,
      "147": 0.04813358187675476,
      "18": 0.048054032027721405,
      "261": 0.04684276133775711,
      "204": 0.04681628569960594,
      "116": 0.04572397097945213,
      "102": 0.0456002913415432,
      "234": 0.045429546386003494,
      "82": 0.045317143201828,
      "282": 0.04462416097521782,
      "96": 0.04453207179903984,
      "422": 0.04378479719161987,
      "262": 0.043388355523347855,
      "131": 0.0432882122695446,
      "33": 0.042062532156705856,
      "466": 0.04148941859602928,
      "396": 0.040889885276556015,
      "142": 0.04067269712686539,
      "154": 0.04058711603283882,
      "186": 0.04012838751077652,
      "97": 0.04012328386306763,
      "180": 0.03887900710105896,
      "164": 0.03863105550408363,
      "288": 0.03817667067050934,
      "69": 0.038151971995830536,
      "121": 0.0380011647939682,
      "30": 0.037446487694978714,
      "341": 0.037419117987155914,
      "36": 0.03734586760401726,
      "1": 0.03731763735413551,
      "508": 0.036928463727235794,
      "382": 0.036143623292446136,
      "130": 0.03526589646935463,
      "4": 0.03491371497511864,
      "92": 0.034202832728624344,
      "297": 0.0341833233833313,
      "132": 0.03392298147082329,
      "153": 0.033594898879528046,
      "269": 0.03354793041944504,
      "339": 0.033476393669843674,
      "441": 0.03332626819610596,
      "35": 0.03266895189881325,
      "100": 0.032321687787771225,
      "249": 0.03202376514673233,
      "454": 0.031977567821741104,
      "253": 0.031426843255758286,
      "218": 0.03128783777356148,
      "371": 0.03128437697887421,
      "75": 0.031167350709438324,
      "257": 0.030094005167484283,
      "363": 0.02989308163523674
    },
    "trial_2_ae": {
      "87": 0.23993591964244843,
      "78": 0.20152512192726135,
      "123": 0.13885661959648132,
      "67": 0.13581694662570953,
      "177": 0.13236932456493378,
      "17": 0.12745115160942078,
      "68": 0.12173867970705032,
      "46": 0.11405551433563232,
      "173": 0.11131873726844788,
      "20": 0.1104792132973671,
      "189": 0.11033033579587936,
      "228": 0.10984420031309128,
      "37": 0.10765088349580765,
      "2": 0.1029532253742218,
      "21": 0.10205212235450745,
      "9": 0.09782152622938156,
      "49": 0.09700308740139008,
      "200": 0.09565167129039764,
      "350": 0.09549448639154434,
      "188": 0.09134011715650558,
      "193": 0.08884920179843903,
      "79": 0.08756580203771591,
      "14": 0.08729802072048187,
      "101": 0.08663219213485718,
      "64": 0.07944473624229431,
      "5": 0.07335859537124634,
      "77": 0.06969572603702545,
      "243": 0.06574966013431549,
      "72": 0.06419502943754196,
      "86": 0.0637313649058342,
      "29": 0.06246049329638481,
      "194": 0.0619344562292099,
      "126": 0.061396997421979904,
      "239": 0.06135895848274231,
      "114": 0.061240170150995255,
      "179": 0.05676978826522827,
      "28": 0.05492749065160751,
      "122": 0.05445447191596031,
      "27": 0.05430428683757782,
      "151": 0.05206902325153351,
      "85": 0.05054498463869095,
      "191": 0.04993969574570656,
      "61": 0.04976709932088852,
      "144": 0.049058329313993454,
      "139": 0.04904966428875923,
      "355": 0.048611629754304886,
      "38": 0.04857323691248894,
      "76": 0.04840061068534851,
      "276": 0.04834449291229248,
      "104": 0.04825393855571747,
      "147": 0.04813358187675476,
      "18": 0.048054032027721405,
      "261": 0.04684276133775711,
      "204": 0.04681628569960594,
      "116": 0.04572397097945213,
      "102": 0.0456002913415432,
      "234": 0.045429546386003494,
      "82": 0.045317143201828,
      "282": 0.04462416097521782,
      "96": 0.04453207179903984,
      "422": 0.04378479719161987,
      "262": 0.043388355523347855,
      "131": 0.0432882122695446,
      "33": 0.042062532156705856,
      "466": 0.04148941859602928,
      "396": 0.040889885276556015,
      "142": 0.04067269712686539,
      "154": 0.04058711603283882,
      "186": 0.04012838751077652,
      "97": 0.04012328386306763,
      "180": 0.03887900710105896,
      "164": 0.03863105550408363,
      "288": 0.03817667067050934,
      "69": 0.038151971995830536,
      "121": 0.0380011647939682,
      "30": 0.037446487694978714,
      "341": 0.037419117987155914,
      "36": 0.03734586760401726,
      "1": 0.03731763735413551,
      "508": 0.036928463727235794,
      "382": 0.036143623292446136,
      "130": 0.03526589646935463,
      "4": 0.03491371497511864,
      "92": 0.034202832728624344,
      "297": 0.0341833233833313,
      "132": 0.03392298147082329,
      "153": 0.033594898879528046,
      "269": 0.03354793041944504,
      "339": 0.033476393669843674,
      "441": 0.03332626819610596,
      "35": 0.03266895189881325,
      "100": 0.032321687787771225,
      "249": 0.03202376514673233,
      "454": 0.031977567821741104,
      "253": 0.031426843255758286,
      "218": 0.03128783777356148,
      "371": 0.03128437697887421,
      "75": 0.031167350709438324,
      "257": 0.030094005167484283,
      "363": 0.02989308163523674
    }
  },
  "safety": {
    "trial_1_safety": 0.3633995056152344,
    "trial_2_safety": 0.3633995056152344
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4808529019355774
  }
}